Back to News
Market Impact: 0.2
Sera Prognostics Reports Third Quarter 2026 Financial Results
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Sera Prognostics reported third-quarter 2026 PreTRM test revenue of $42,000, up 163% year over year. The article text ends before providing the reported ending balance of cash, cash equivalents and marketable investment securities, so no further financial details are available.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
SERA0.35
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook